FR
Search all our fact sheets and resources
Healthy pregnancy hub

Fexofenadine (Allegra®)

Last Update: 20 Jun 2025

Welcome to our fact sheet on fexofenadine during pregnancy and breastfeeding or chestfeeding. This information is based on available published literature. It should not take the place of medical care and advice from your healthcare provider.

The HEALTHY PREGNANCY HUB team is collaborating with MotherToBaby to share information on this topic. The original version is available here (August 2023).

Serene, our chatbot, can also answer your questions about medications during pregnancy.

Please note that this fact sheet is based on United States information and has been adapted for Canada, with a review by our Canadian experts. Minor differences may exist between the two countries. Always consult your healthcare professional for information tailored to your situation.

1. What is fexofenadine?

Fexofenadine is an over-the-counter antihistamine that has been used to treat and prevent allergy symptoms such as sneezing, runny nose, watery eyes, itching, and hives. Some brand names are Allegra® and Aller-Ease®. 

Sometimes when people find out they are pregnant, they think about changing how they take their medication, or stopping their medication altogether. However, it is important to talk with your healthcare providers before making any changes to how you take your medication. Your healthcare providers can talk with you about the benefits of treating your condition and the risks of untreated illness during pregnancy. 

2. What does research say about the risks during pregnancy?

I take fexofenadine. Can it make it harder for me to get pregnant?

Studies have not been done in humans to see if taking fexofenadine could make it harder to get pregnant. Animal studies have not shown that taking fexofenadine would affect fertility (ability to get pregnant). 

Does taking fexofenadine increase the chance of miscarriage? 

Miscarriage is common and can occur in any pregnancy for many different reasons. One study that compared the use of fexofenadine to other common allergy medications during pregnancy found no difference in the chance of miscarriage in those who took fexofenadine. 

Does taking fexofenadine increase the chance of birth defects? 

Every pregnancy starts out with a 3-5% chance of having a birth defect. This is called the background risk. Studies on fexofenadine have not found an increased chance of birth defects. 

Does taking fexofenadine in pregnancy increase the chance of other pregnancy-related problems?

A study that compared the use of fexofenadine to other similar antihistamines did not find an increased chance for other pregnancy-related problems, such as preterm delivery (birth before week 37) or low birth weight (weighing less than 5 pounds, 8 ounces [2500 grams] at birth). 

Does taking fexofenadine in pregnancy affect future behavior or learning for the child?

Studies have not been done to see if fexofenadine can cause behavior or learning issues for the child. 

3. Breastfeeding​ or chestfeeding​ while taking fexofenadine

Fexofenadine gets into human milk in small amounts. This amount is likely too low to cause problems for the baby. Be sure to talk to your healthcare provider about all your breastfeeding or chestfeeding questions. Be sure to talk to your healthcare provider about all your breastfeeding or chestfeeding questions. 

4. What about fathers and sperm donors?

If a male takes fexofenadine, could it affect fertility or increase the chance of birth defects?

Studies have not been done to see if fexofenadine could affect a male’s fertility (ability to get partner pregnant) or increase the chance of birth defects. In general, exposures that fathers or sperm donors have are unlikely to increase risks to a pregnancy. For more information, please see the MotherToBaby fact sheet Paternal Exposures here.

Key points

  • Fexofenadine (Allegra®) is a medication from the antihistamine group that you can buy without a prescription. Antihistamines are used to help with allergy symptoms like sneezing, runny nose, or itchy eyes.
  • There are not enough studies to know if fexofenadine can make it harder to get pregnant or affect a child’s behavior or learning in the future.
  • So far, studies have not found a higher chance of birth defects, miscarriage, preterm birth or low birth weight, based on comparisons with other allergy medications.
  • There are no studies on whether fexofenadine affects a child’s
  • Fexofenadine can pass into breast milk in small amounts, but this is likely too little to cause problems for most babies.
  • There are no studies on how fexofenadine affects male fertility or birth defect risks, but medicine taken by the father or sperm donor is unlikely to affect the baby.
  • Always talk with your healthcare professionals before starting or changing your medication during pregnancy or while breastfeeding or chestfeeding.

References

Please click here for references. 

URL copied!

Disclaimer

HEALTHY PREGNANCY HUB provides a source of information validated by health professionals; however, this information is provided for informational purposes only and should not replace professional advice. Medical standards and practices evolve as new data becomes available, so it is imperative to consult your doctor or a qualified health professional for any questions or concerns regarding your health without delay or omission. It is the responsibility of your treating physician or any other health professional, based on their independent experience and knowledge of the patient, to determine the best way to evaluate and treat you.

HEALTHY PREGNANCY HUB does not specifically recommend or endorse any test, practitioner, treatment, product, or opinion mentioned on our platform. HEALTHY PREGNANCY HUB also does not replace the individual patient assessment based on the examination by the healthcare provider of each patient and the consideration of laboratory data and other patient-specific factors.

The use of the information available on our site is at your own risk. No person involved in the creation, production, promotion, or marketing of HEALTHY PREGNANCY HUB guarantees or represents, expressly or implicitly, anything regarding the information available on the platform, which is provided “as it is”. All warranties are expressly excluded and disclaimed, including but not limited to implied warranties of merchantability or fitness for a particular purpose, as well as any warranties arising by law or otherwise in law or from trade or usage. Any statements or representations made by any other person or entity are void.

While consulting symptoms or other medical information on our platform may guide your discussions with your healthcare professional, this information should not be used to make a medical diagnosis or determine treatment. Before making changes to your supplement or medication regimen, please discuss with your medical team or contact 811 (Canada) to ensure the relevance of these changes to your individual situation.

Credits
MotherToBaby
Organization of Teratology Information Specialists (OTIS)
View source
Émy Roberge
Centre hospitalier universitaire Sainte-Justine
Evelyne Rey
CHU Sainte-Justine
Brigitte Martin
Centre Hospitalier Universitaire Sainte-Justine
Sherif Eltonsy
University of Manitoba
Sacha Williams
McGill University
Modupe Tunde-Byass
University of Toronto

Associated Fact Sheets

You want to know more about this topis? Discover our associated Fact Sheets!

Associated Resources

Want to know more? Discover our other contents associated to the topic.

Partners

Your pregnancy during COVID-19
uOttawa
University of Calgary
University of British Columbia
University of Saskatchewan
University of Manitoba
University of Alberta
Unité de soutien SSA
UDEM
Stratos
SOGC
RQRM
QTNPR
QPC
PWHR
Public Health Agency of Canada
PregMed France
SPOR
MPrint
Mitacs
Médicaments Grossesse
McGill
Médicament Québec
FRQ
Perinatal Network
CIHR
IQVIA
iPOP
Institut national de santé publique du Québec
INRS
Innovative Medicines Canada
IN-uTERO
Immerscience
Groww
Enrich
Design Develop Discover
CUSM
CIHR
CHU Sainte-Justine
Centre of Excellence on Partnership with Patients and the Public
CAN-AIM
Canadian Pharmacogenomics Network for Drug Safetry
CAMCCO
CAMCCO-L
C4T
BORN Ontario
Black Physicians of Canada
BC Children's Hospital
Alberta Health Services
MICYRN
UQAT
Dalhousie University